Vincent Vinciguerra, MD
Hematology & Oncology Physician in Lake Success, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Vincent Vinciguerra, MD reported a CMS MIPS final score of 74.1/100 - below the 83.5 national average - and filed 405 Medicare Part D claims in 2023.
- 74.1/100
- MIPS score · -9 vs avg
- 405
- Part D claims, 2023
- 68%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1003961756 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1003961756
- ENUM-MID 2007
- TAX-MID 11K Hematology &
- MIPS-BELOW 74.1/100
- RX-LIGHT 405
- BOOK-LIGHT 967 in New York
- PHOTO-FINISH Liat Dagan · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Vinciguerra · th…
Vinciguerra · this provider
74.1 MIPS pts
- Liat Dagan · hig…
Liat Dagan
74.1 MIPS pts
- Jean Lee · near
Jean Lee
74.1 MIPS pts
- Julia Schaefer-C…
Julia Schaefer-Cutillo
74.1 MIPS pts
- Jocelyn Wozney ·…
Jocelyn Wozney
74.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Vincent Vinciguerra, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
74 ≥ 13th percentile 13% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Vincent Vinciguerra, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Vincent Vinciguerra, MD writes more Part D claims than 31% of them and scores higher on MIPS quality than 11% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Vincent Vinciguerra, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Vincent Vinciguerra, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Vincent Vinciguerra, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Hematology & Oncology Physician ranks #70 among New York's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Vincent Vinciguerra, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 74.1/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Hematology & Oncology Physician US NPIs
74.1/100 MIPS final score - 9.4 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 60.2. Cost dim: 56.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1003961756 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 01/24/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Vincent Vinciguerra, MD's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1003961756 is the unique 10-digit identifier CMS uses to link Vinciguerra across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Vincent Vinciguerra, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Vincent Vinciguerra, MD. Source: openpaymentsdata.cms.gov.
Total received
$18
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Education
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Vincent Vinciguerra, MD. To verify Vincent Vinciguerra, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
32% brand-name claims vs 68% generic, on 405 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 679
- Total Day Supply
- 19,110
- Brand vs Generic
- 32% brand / 68% generic
- Brand Drug Cost
- $1.6M
- Generic Drug Cost
- $13K
- Opioid Claims
- 16 (4.0% rate)
- Antibiotic Claims
- 15
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 1.98
- Gender Split
- 76% female / 24% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Vincent Vinciguerra, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
64 claims
- Ibrance
Ibrance
37 claims
- Letrozole
Letrozole
26 claims
- Exemestane 25
Exemestane
25 claims
- Stivarga 20
Stivarga
20 claims
- Omeprazole 19
Omeprazole
19 claims
- Oxycodone Hcl 12
Oxycodone Hcl
12 claims
- Creon 11
Creon
11 claims
| Drug | Claims |
|---|---|
| Anastrozole | 64 |
| Ibrance Palbociclib | 37 |
| Letrozole | 26 |
| Exemestane | 25 |
| Stivarga Regorafenib | 20 |
| Omeprazole | 19 |
| Oxycodone Hcl | 12 |
| Creon Lipase/Protease/Amylase | 11 |
| Kisqali Ribociclib Succinate | 11 |
| Pantoprazole Sodium | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Vincent Vinciguerra, MD fits within the Hematology & Oncology Physician landscape nationally.
Vincent Vinciguerra, MD's 405 claims are below the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Vinciguerra, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (74.1 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Vinciguerra.
One of 967 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Vincent Vinciguerra, MD's specialty? ▼
How much does Vincent Vinciguerra, MD prescribe under Medicare Part D? ▼
What is Vincent Vinciguerra, MD's Medicare quality score? ▼
Where is Vincent Vinciguerra, MD located? ▼
What is Vincent Vinciguerra, MD's NPI number? ▼
Does Vincent Vinciguerra, MD prescribe more brand-name or generic drugs? ▼
Does Vincent Vinciguerra, MD prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Vincent Vinciguerra, MD prescribe most often? ▼
Does Vincent Vinciguerra, MD accept Medicare? ▼
How can I verify Vincent Vinciguerra, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.